Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy and allotransplantation

K J Wood1

  • 1Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, UK. kathryn.wood@nds.ox.ac.uk

Current Opinion in Immunology
|November 22, 1997
PubMed
Summary

Gene therapy offers a promising approach for delivering therapeutic proteins in transplantation. This method could prevent graft rejection and improve outcomes compared to current systemic treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo-expanded human CD19<sup>+</sup>TIM-1<sup>+</sup> regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Nature communications·2022
Same author

Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

The role of donor-specific HLA alloantibodies in liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Area of Science:

  • Biotechnology
  • Immunology
  • Transplantation Medicine

Background:

  • Gene therapy's potential for in vivo protein delivery is gaining traction.
  • Current transplantation protocols rely on systemic immunosuppression, which has limitations.

Purpose of the Study:

  • To explore gene transfer strategies for targeted delivery of immunomodulatory molecules in transplantation.
  • To investigate methods for preventing graft rejection, ischemic injury, and inducing donor-specific tolerance.

Main Methods:

  • Gene transfer techniques for delivering therapeutic proteins like cytokines and antibodies.
  • Targeted delivery to the graft or specific recipient sites.

Main Results:

  • Gene therapy allows for localized delivery of immunomodulatory agents.
  • Potential to prevent graft rejection and ischemic injury.
  • Possibility of inducing tolerance to donor alloantigens.

Conclusions:

  • Gene therapy presents a localized and potentially more effective alternative to systemic immunosuppression in transplantation.
  • This approach could significantly improve graft survival and reduce complications.

Related Experiment Videos